Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021

SELL
$33.49 - $37.77 $10.9 Million - $12.3 Million
-324,344 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $1.05 Million - $1.33 Million
31,323 Added 10.69%
324,344 $11.9 Million
Q3 2020

Oct 27, 2020

SELL
$31.75 - $37.25 $50,641 - $59,413
-1,595 Reduced 0.54%
293,021 $10.8 Million
Q2 2020

Aug 06, 2020

SELL
$30.12 - $36.54 $17,770 - $21,558
-590 Reduced 0.2%
294,616 $9.63 Million
Q1 2020

Jun 09, 2020

SELL
$27.03 - $38.62 $1.59 Million - $2.27 Million
-58,659 Reduced 16.58%
295,206 $9.64 Million
Q4 2019

Jan 24, 2020

BUY
$32.92 - $37.36 $255,097 - $289,502
7,749 Added 2.24%
353,865 $13.9 Million
Q3 2019

Oct 31, 2019

BUY
$32.49 - $42.13 $12,346 - $16,009
380 Added 0.11%
346,116 $12.4 Million
Q2 2019

Jul 25, 2019

SELL
$36.98 - $41.52 $20,523 - $23,043
-555 Reduced 0.16%
345,736 $15 Million
Q1 2019

Apr 25, 2019

BUY
$37.5 - $41.2 $283,312 - $311,266
7,555 Added 2.23%
346,291 $14.7 Million
Q4 2018

Jan 28, 2019

SELL
$38.47 - $43.86 $64,244 - $73,246
-1,670 Reduced 0.49%
338,736 $14.8 Million
Q3 2018

Oct 29, 2018

SELL
$34.47 - $41.81 $19,337 - $23,455
-561 Reduced 0.16%
340,406 $15 Million
Q2 2018

Aug 01, 2018

SELL
$32.98 - $35.16 $4.27 Million - $4.55 Million
-129,494 Reduced 27.52%
340,967 $12.4 Million
Q1 2018

May 01, 2018

BUY
$31.91 - $37.02 $33,026 - $38,315
1,035 Added 0.22%
470,461 $16.7 Million
Q4 2017

Jan 30, 2018

BUY
$33.26 - $35.29 $2.09 Million - $2.22 Million
62,865 Added 15.46%
469,426 $17 Million
Q3 2017

Oct 25, 2017

BUY
$31.0 - $34.15 $12.6 Million - $13.9 Million
406,561
406,561 $14.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Braun Stacey Associates Inc Portfolio

Follow Braun Stacey Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.